PHASTAR Names Ping-Chung Chang as Head of China Development and Global Delivery  

 Beijing, China and London, UK, April 20, 2022 – PHASTAR, a global specialist biometrics contract research organization (CRO) offering industry leading data management, data science, statistical consulting, and clinical trial reporting services, today announces that Ping-Chung Chang has joined the company as Head of China Development and Global Delivery. Ping brings deep experience in CRO operations, business excellence, biotech/biopharma, research and development process, and regulatory submissions. Headquartered in PHASTAR’s Beijing office, Ping will be responsible for building China development and delivery into PHASTAR’s global business advantage.  

“We are delighted to have someone with Ping’s expertise join our team to expand our presence in the Asia Pacific region,” said Andrew MacGarvey, Chief Executive Officer, PHASTAR. “Ping’s wealth of experience in this market will help continue to drive our success in our latest phase of growth, enhance our overall global delivery excellence, and realize our full business potential.”

Continue Reading

PHASTAR Names Cary Morrill as Chief People Officer

Cary Morrill headshot

Durham, NC and London, UK – 21 October 2021PHASTAR, a global specialist biometrics contract research organization offering industry leading data management, data science, statistical consulting, and clinical trial reporting services, announced today the appointment of Cary Morrill as Chief People Officer.

With an MA from Columbia University and a BA from the University of Wisconsin, Cary brings to PHASTAR over 25 years’ experience in human resources across industry leading CRO, executive search, and strategy consulting companies.

The depth of her experience in developing and executing human resource and recruitment strategies, including succession planning, talent acquisition and management, change management, organizational and performance management, training and development, and compensation, will be of critical importance to PHASTAR as the company enters into its next stage of growth.

Continue Reading

Image depicting PHASTAR and AstraZeneca as joint winners of the ACDM innovation award

PHASTAR announced as joint winner of ACDM Innovation in Management of Clinical Data Award

London, UK and Durham, NC – 22 September 2021PHASTAR, a global specialist biometrics contract research organization offering industry leading data management, data science, statistical consulting and clinical trial reporting services, was announced as a joint winner of the 2021 Innovation in the Management of Clinical Data Award by the Association for Clinical Data Management (ACDM).

The award was in recognition of the work done by PHASTAR data scientists and data managers to develop a novel AI and rule-based approach for the production of auto-generated queries used to identify potential data issues and inconsistencies in clinical trial data. The PHASTAR team integrated the role of the human expert with intelligent process automation through a targeted approach. They are able to discover hotspots of data quality issues on studies through the application of AI (NLP) approaches to the meta data, identifying problematic forms and variables and are now building labelled data sets to which machine learning methods may be applied.

Continue Reading

PHASTAR Announces Changes in Management Structure

PHASTAR Announces Changes in Management Structure

London, UK and Durham, NC – August 6 2021 – As part of PHASTAR's continued growth and success, we are announcing a change in our management structure. From 1st August, Kevin Kane will take on the role of President of PHASTAR. Kevin will continue to work in the business helping to develop new strategic opportunities and ensuring the culture PHASTAR is famous for is maintained across all of PHASTAR’s operating regions. As President, Kevin will continue to work with the board to ensure we maintain focus on quality and excellence in the work we deliver. 

At the same time, Andrew MacGarvey has been appointed to the CEO role. Andrew has managed large parts of the business since joining in 2018 and will now take on the responsibility of delivering the company strategy and managing the business as a whole. 

Continue Reading

PHASTAR Names Chuck Gelb as Chief Commercial Officer

PHASTAR Names Chuck Gelb as Chief Commercial Officer

London, UK and Durham, NC – 3 August 2021 – PHASTAR, a global specialist biometrics contract research organization offering industry leading data management, data science, statistical consulting and clinical trial reporting services, announced today the appointment of Chuck Gelb as Chief Commercial Officer.

Holding an MBA in Pharmaceutical Management and an MA in Biotechnology, Chuck brings to PHASTAR over 20 years’ experience across pharmaceutical companies and CROs. His unique blend of experience provides critical insight into the needs of pharmaceutical, biotechnology and medical device sponsors, as well as the knowledge to build and manage a large, global sales and marketing team through periods of exponential growth. Furthermore, Chuck is skilled in building brand awareness, vision and market leadership as well as developing global sales strategies.

Continue Reading